DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine

ABSTRACT:

SUBMITTER: Anastasopoulou E 

PROVIDER: S-EPMC4652460 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature